Literature DB >> 15356809

Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.

Ali A El Solh1, Celestino Pietrantoni, Abid Bhat, Milapchand Bhora, Eileen Berbary.   

Abstract

BACKGROUND: Knowledge of the determinant factors responsible for the presence of antimicrobial-resistant pathogens in severe nursing home-acquired pneumonia (NHAP) is deemed essential for antibiotic selection.
METHODS: Data for institutionalized patients with cases of severe pneumonia confirmed by culture of protected bronchoalveolar lavage fluid samples (> or =10(3) cfu/mL) during a 36-month period were analyzed. A classification tree with a sensitivity of 100% was developed using binary recursive partitioning to predict which patients are unlikely to have drug-resistant pathogen (DRP)-related pneumonia.
RESULTS: Of the 88 patients who satisfied the inclusion criteria, 17 had at least 1 DRP recovered from the lower respiratory tract. The predictor variables were the Activity of Daily Living score and previous use of antibiotics. Prospective application of the model in 47 patients over a 24-month period yielded a sensitivity of 100% (95% confidence interval [CI], 71.3%-100%) and a specificity of 69.4% (95% CI, 51.9%-83.6%).
CONCLUSIONS: The use of the tree may provide a more rational basis for selecting initial therapy for severe NHAP after it is validated in a large prospective study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356809     DOI: 10.1086/422317

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Non-adherence to guidelines: an avoidable cause of failure of empirical antimicrobial therapy in the presence of difficult-to-treat bacteria.

Authors:  Frédéric Garcin; Marc Leone; François Antonini; Aude Charvet; Jacques Albanèse; Claude Martin
Journal:  Intensive Care Med       Date:  2009-09-24       Impact factor: 17.440

3.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

Review 4.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

5.  Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.

Authors:  Brandon J Webb; Kristin Dascomb; Edward Stenehjem; Holenarasipur R Vikram; Neera Agrwal; Kenneth Sakata; Kathryn Williams; Bruno Bockorny; Kavitha Bagavathy; Shireen Mirza; Mark Metersky; Nathan C Dean
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

6.  Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.

Authors:  Christopher R Frei; Sylvie Rehani; Grace C Lee; Natalie K Boyd; Erene Attia; Ashley Pechal; Rachel S Britt; Eric M Mortensen
Journal:  Pharmacotherapy       Date:  2017-02-03       Impact factor: 4.705

7.  One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.

Authors:  Joe L Hsu; Andrew M Siroka; Mark W Smith; Mark Holodniy; G Umberto Meduri
Journal:  Int J Infect Dis       Date:  2011-03-09       Impact factor: 3.623

Review 8.  [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections].

Authors:  O Leroy
Journal:  Med Mal Infect       Date:  2006-11-13       Impact factor: 2.152

9.  Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.

Authors:  Christopher R Frei; Eric M Mortensen; Laurel A Copeland; Russell T Attridge; Mary Jo V Pugh; Marcos I Restrepo; Antonio Anzueto; Brandy Nakashima; Michael J Fine
Journal:  BMC Health Serv Res       Date:  2010-05-27       Impact factor: 2.655

10.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.